Altered expression of talin 1 in peripheral immune cells points to a significant role of the innate immune system in spontaneous autoimmune uveitis

Journal of Proteomics

Volumn 75, Issue 14, 2012, Pages 4536-4544

  Degroote, Roxane L ^a   Hauck, Stefanie M ^b   Kremmer, Elisabeth ^b   Amann, Barbara ^a   Ueffing, Marius ^b,c   Deeg, Cornelia A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Autoimmune; DIGE; Granulocytes; Immune disease; Immunoproteomics; Talin 1

Indexed keywords

BETA INTEGRIN; TALIN; TALIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DOWN REGULATION; GRANULOCYTE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LEUKOCYTE FUNCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPONTANEOUS AUTOIMMUNE UVEITIS; UVEITIS;

ANIMALS; AUTOIMMUNE DISEASES; GENE EXPRESSION REGULATION; HORSE DISEASES; HORSES; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; TALIN; UVEITIS;

ANIMALIA; EQUIDAE;

EID: 84863834223     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.01.023     Document Type: Article

References (30)

1. Luger D., Caspi R. New perspectives on effector mechanisms in uveitis. Semin Immunopathol 2008, 30:135-143.
2. Deeg C.A., Reese S., Gerhards H., Wildner G., Kaspers B. The uveitogenic potential of retinal S-antigen in horses. Invest Ophthalmol Vis Sci 2004, 45:2286-2292.
3. Hauck S.M., Dietter J., Kramer R.L., Hofmaier F., Zipplies J.K., Amann B., et al. Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Mol Cell Proteomics 2010 Oct, 9(10):2292-2305. [Electronic publication 2010 Jul 4].
4. Deeg C.A., Pompetzki D., Raith A.J., Hauck S.M., Amann B., Suppmann S., et al. Identification and functional validation of novel autoantigens in equine uveitis. Mol Cell Proteomics 2006, 5:1462-1470.
5. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473-477.
6. Deeg C.A., Amann B., Raith A.J., Kaspers B. Inter- and intramolecular epitope spreading in equine recurrent uveitis. Invest Ophthalmol Vis Sci 2006, 47:652-656.
7. Eberhardt C., Amann B., Feuchtinger A., Hauck S.M., Deeg C.A. Differential expression of inwardly rectifying K+ channels and aquaporins 4 and 5 in autoimmune uveitis indicates misbalance in Müller glial cell-dependent ion and water homeostasis. Glia 2011, 59:697-707.
8. Eberhardt C., Amann B., Stangassinger M., Hauck S.M., Deeg C.A. Isolation, characterization and establishment of an equine retinal glial cell line: a prerequisite to investigate the physiological function of Muller cells in the retina. J Anim Physiol Anim Nutr (Berl) 2011, [Epub ahead of print:]. 10.1111/j.1439-0396.2011.01147.x.
9. Deeg C.A., Ehrenhofer M., Thurau S.R., Reese S., Wildner G., Kaspers B. Immunopathology of recurrent uveitis in spontaneously diseased horses. Exp Eye Res 2002, 75:127-133.
10. Deeg C.A., Hauck S.M., Amann B., Pompetzki D., Altmann F., Raith A., et al. Equine recurrent uveitis-a spontaneous horse model of uveitis. Ophthalmic Res 2008, 40:151-153.
11. Deeg C.A., Altmann F., Hauck S.M., Schoeffmann S., Amann B., Stangassinger M., et al. Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier. Proteomics 2007, 7:1540-1548.
12. Hauck S.M., Dietter J., Kramer R.L., Hofmaier F., Zipplies J.K., Amann B., et al. Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Mol Cell Proteomics 2010, 9:2292-2305.
13. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
14. Deeg C.A., Thurau S.R., Gerhards H., Ehrenhofer M., Wildner G., Kaspers B. Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease. Eur J Immunol 2002, 32:2598-2606.
15. Caspi R.R., Roberge F.G., McAllister C.G., el-Saied M., Kuwabara T., Gery I., et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol 1986, 136:928-933.
16. David R.C. Focal adhesions - the cytoskeletal connection. Curr Opin Cell Biol 2000, 12:133-139.
17. Elliott P.R., Goult B.T., Kopp P.M., Bate N., Grossmann J.G., Roberts G.C.K., et al. The structure of the talin head reveals a novel extended conformation of the FERM domain. Structure 2010, 18:1289-1299.
18. Tadokoro S., Shattil S.J., Eto K., Tai V., Liddington R.C., de Pereda J.M., et al. Talin binding to integrin β tails: a final common step in integrin activation. Science 2003, 302:103-106.
19. Calderwood D.A. Integrin activation. J Cell Sci 2004, 117:657-666.
20. Horwitz A., Duggan K., Buck C., Beckerle M.C., Burridge K. Interaction of plasma membrane fibronectin receptor with talin-a transmembrane linkage. Nature 1986, 320:531-533.
21. Weiner H.L. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?. Ann Neurol 2009, 65:239-248.
22. Vaknin-Dembinsky A., Balashov K., Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol 2006, 176:7768-7774.
23. Karni A., Abraham M., Monsonego A., Cai G., Freeman G.J., Hafler D., et al. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J Immunol 2006, 177:4196-4202.
24. Ekinci N.S., Alpsoy E., Karakas A.A., Yilmaz S.B., Yegin O. IL-17A has an important role in the acute attacks of Behcet's disease. J Invest Dermatol 2010, 130:2136-2138.
25. Deeg C.A., Kaspers B., Gerhards H., Thurau S.R., Wollanke B., Wildner G. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Invest Ophthalmol Vis Sci 2001, 42:393-398.
26. Sampath R., Gallagher P.J., Pavalko F.M. Cytoskeletal interactions with the leukocyte integrin β2 cytoplasmic tail. J Biol Chem 1998, 273:33588-33594.
27. Cox D., Brennan M., Moran N. Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov 2010, 9:804-820.
28. Shattil S.J., Kim C., Ginsberg M.H. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010, 11:288-300.
29. Richard O.H. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
30. Green J.A., Berrier A.L., Pankov R., Yamada K.M. β1 integrin cytoplasmic domain residues selectively modulate fibronectin matrix assembly and cell spreading through talin and Akt-1. J Biol Chem 2009, 284:8148-8159.